CRISPR THERAPEUTIC revenue breakdown overview

CRISPR THERAPEUTIC revenue for the last year amounted to 312.53 M CHF, the most of which — 311.52 M CHF — came from its highest performing source at the moment, Collaboration, the year earlier bringing 403.18 k CHF. The greatest contribution to the revenue figure was made by Switzerland and United States — last year it brought CRISPR THERAPEUTIC 312.53 M CHF, and the year before that — 1.11 M CHF.